Shariah compliance overview
Not HalalCytomX Therapeutics, Inc. (CTMX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications.
CytomX Therapeutics, Inc. (CTMX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 6.40%Limit 5%Fail
- Interest-bearing debt
- 1.29%Limit 30%Pass
- Interest-bearing securities and assets
- 41.80%Limit 30%Fail
- Dividend purification
- 6.40%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about CytomX Therapeutics, Inc. (CTMX). Current Akinda screening label: Not Halal.
